The top 3 holdings of LABU are EXACT Sciences (EXAS) (2.356%), Alnylam Pharmaceuticals (ALNY) (2.213%) and Neurocrine Biosciences (NBIX) (2.12%).

FUND	HOLDING	% OF FUND	VALUE ($)
LABU	EXACT Sciences (EXAS)	2.356%	$13.1M
LABU	Alnylam Pharmaceuticals (ALNY)	2.213%	$12.3M
LABU	Neurocrine Biosciences (NBIX)	2.12%	$11.8M
LABU	Natera (NTRA)	2.098%	$11.7M
LABU	United Therapeutics (UTHR)	1.931%	$10.8M
LABU	Incyte (INCY)	1.802%	$10M
LABU	Gilead Sciences (GILD)	1.788%	$10M
LABU	Biogen (BIIB)	1.709%	$9.5M
LABU	Exelixis (EXEL)	1.698%	$9.5M
LABU	Vertex Pharmaceuticals (VRTX)	1.689%	$9.4M
LABU	Insmed (INSM)	1.685%	$9.4M
LABU	Amgen (AMGN)	1.675%	$9.3M
LABU	Blueprint Medicines (BPMC)	1.646%	$9.2M
LABU	AbbVie (ABBV)	1.623%	$9M
LABU	Regeneron Pharmaceuticals (REGN)	1.613%	$9M
LABU	Madrigal Pharmaceuticals (MDGL)	1.41%	$7.8M
LABU	Moderna (MRNA)	1.399%	$7.8M
LABU	Biomarin Pharmaceutical (BMRN)	1.323%	$7.4M
LABU	BridgeBio Pharma (BBIO)	1.134%	$6.3M
LABU	TG Therapeutics (TGTX)	1.112%	$6.2M
LABU	Revolution Medicines (RVMD)	1.073%	$6M
LABU	Halozyme Therapeutics (HALO)	1.052%	$5.9M
LABU	Summit Therapeutics (SMMT)	1.04%	$5.8M
LABU	Ionis Pharmaceuticals (IONS)	0.994%	$5.5M
LABU	Crispr Therapeutics (CRSP)	0.945%	$5.3M

Holdings are tracked for approximately 2000 ETFs.